Tag: aquaporin-2
29
OctoberHow Tolvaptan Affects Blood Pressure in Kidney Disease Patients
Tolvaptan helps control blood pressure in kidney disease by reducing fluid overload without affecting electrolytes. It’s most effective in ADPKD patients, slowing kidney damage and lowering systolic pressure by 4-6 mmHg. Requires liver monitoring and hydration.
Recent posts
-
20 Oct 2025
Raltegravir for Post-Exposure Prophylaxis: Is It a Viable Option?
-
23 Dec 2025
Biologic Therapies: How to Inject Safely and Avoid Infections
-
8 Oct 2025
Antimalarial Medications: QT and CYP Interactions You Can't Ignore
-
10 Oct 2025
How Liver Failure Increases Heart Disease Risk
-
26 Jan 2026
Clinical Trial Eligibility: How Biomarkers Shape Inclusion Criteria in Cancer Care